Search results for "ffpe challenges"

Explore how a partnership between a lead researcher in sexual health and a molecular diagnostics innovator helped to overcome the therapeutic hurdles that come with antibiotic resistance

World-renowned laboratories’ workflow and performance studies succeeded in KPIs such as turnaround time, throughput, hands-on system time, and assay performance

bioMérieux conducts in-depth analyses of its molecular tests on emerging variants of concern

In this SelectScience special feature, learn about the latest in next-generation sequencing (NGS) technologies and techniques

Elevating respiratory research through precise inhalation technology

Study aims to develop a rapid point-of-care diagnostic based on multiple biomarkers to detect emergent sepsis

Discover insights on topics from lab automation and drug development to clinical LC-MS/MS and point-of-care testing

Antibody expert, Dr. Chelcie Eller, shares how to achieve reliable and reproducible high-throughput drug and biomarker screening

The genomic sequencing platform facilitates the discovery and action of new, potentially harmful coronavirus mutations worldwide

Prof. Peter Wright explains why ultra-high field NMR is becoming ever more crucial to the study of disordered proteins

Global leaders convene to map new paths to diagnose and treat Alzheimer’s, Multiple Sclerosis, and other neurodegenerative diseases that afflict one in six people

The new kit is designed to allow researchers to easily and consistently generate muscle from human pluripotent stem cells

The collaboration is focused on delivering compatible digital pathology workflow solutions

Join this expert webinar on May 28 to understand best practices for optimal sorting of large, fragile cells, immunophenotyping panels, and nuclei

Download this infographic from Sartorius to find out more about how flow cytometry platforms can be used for immune cell profiling

Explore best practices and understand the benefits of making the switch to spectral flow cytometry

Survey finds fear and misconceptions around hepatitis discourage testing, with more than half of respondents assuming they are not at risk